Rod Gerardo and Ellen Ancisco

0 statements · 0 topics · summaries given as host listed separately

Nothing matches these filters — clear the search or widen the filters.

Summaries Rod gave as host · 75 summaries

Recaps of other experts' statements, not Rod's own clinical position.

Summaries Rod gave as host · Congenital Lung Lesions (CPAM) 15 summaries

Open the Congenital Lung Lesions (CPAM) collection →

The Full Story on CPAMs

▶ Ep 24 · 5:12
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The Stocker classification for CPAMs ranges from type 0 to type 4, moving from proximal to distal in the bronchial tree, with type 1 (distal bronchi/proximal bronchioles) being most common at 60-70% of cases. ↗
▶ Ep 24 · 6:57
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs typically grow during the first 20-25 weeks of gestation and plateau around week 28. ↗
▶ Ep 24 · 8:02
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The presence of hydrops is the strongest prognostic indicator of mortality in these patients. ↗
▶ Ep 24 · 8:02
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The presence of hydrops is the strongest prognostic indicator of mortality in fetuses with CPAMs. ↗
▶ Ep 24 · 8:41
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The CPAM volume ratio (CVR) is calculated as the CPAM's length times width times height times 0.52 divided by the head circumference. ↗
▶ Ep 24 · 9:14
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: In patients with CVR over 1.6, it is estimated that 75% develop hydrops. ↗
▶ Ep 24 · 10:14
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs are differentiated as microcystic (less than 5 millimeters) or macrocystic (larger than 5 millimeters). ↗
▶ Ep 24 · 22:25
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs are not well-visualized on chest X-rays and can regress or get smaller over time. ↗
▶ Ep 24 · 24:40
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: In the United States, most surgeons resect CPAMs even if asymptomatic, while in Europe and Canada, surgeons sometimes choose to monitor asymptomatic lesions and avoid surgery. ↗
▶ Ep 24 · 25:29
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The main reasons for operating on asymptomatic CPAMs are: risk of malignancy both at resection and from malignant transformation later, risk of infection that will make surgery more difficult, and better compensatory lung growth if operating sooner in life. ↗
▶ Ep 24 · 26:03
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: Thoracoscopic lobectomy risks include bleeding, prolonged post-op mechanical ventilation, infections, air leak, pneumothorax, nerve injury, and mortality. ↗
▶ Ep 24 · 27:47
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The particular malignancy associated with CPAM is pleuropulmonary blastoma (PPB), with risk that the lesion at birth already has malignancy and risk of malignant transformation over a person's life. ↗
▶ Ep 24 · 30:17
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: A recent study published in April 2021 found that no prenatally diagnosed lesions had malignancy, but 10% of patients diagnosed postnatally had malignancy in their resected mass. ↗
▶ Ep 24 · 52:39
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The incidence of CPAMs is estimated to be about 1 in every 8,000 to 35,000 births. ↗
▶ Ep 24 · 52:53
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: 60% of prenatally diagnosed lung lesions are CPAMs, making them the most common prenatal lung lesion. ↗
Summaries Rod gave as host · Congenital Pulmonary Airway Malformation 15 summaries

Open the Congenital Pulmonary Airway Malformation collection →

The Full Story on CPAMs

▶ Ep 20 · 5:12
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The Stocker classification for CPAMs ranges from type 0 to type 4, moving from proximal to distal in the bronchial tree, with type 1 (distal bronchi/proximal bronchioles) being most common at 60-70% of cases. ↗
▶ Ep 20 · 6:57
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs typically grow during the first 20-25 weeks of gestation and plateau around week 28. ↗
▶ Ep 20 · 8:02
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The presence of hydrops is the strongest prognostic indicator of mortality in fetuses with CPAMs. ↗
▶ Ep 20 · 8:02
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The presence of hydrops is the strongest prognostic indicator of mortality in these patients. ↗
▶ Ep 20 · 8:41
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The CPAM volume ratio (CVR) is calculated as the CPAM's length times width times height times 0.52 divided by the head circumference. ↗
▶ Ep 20 · 9:14
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: In patients with CVR over 1.6, it is estimated that 75% develop hydrops. ↗
▶ Ep 20 · 10:14
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs are differentiated as microcystic (less than 5 millimeters) or macrocystic (larger than 5 millimeters). ↗
▶ Ep 20 · 22:25
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs are not well-visualized on chest X-rays and can regress or get smaller over time. ↗
▶ Ep 20 · 24:40
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: In the United States, most surgeons resect CPAMs even if asymptomatic, while in Europe and Canada, surgeons sometimes choose to monitor asymptomatic lesions and avoid surgery. ↗
▶ Ep 20 · 25:29
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The main reasons for operating on asymptomatic CPAMs are: risk of malignancy both at resection and from malignant transformation later, risk of infection that will make surgery more difficult, and better compensatory lung growth if operating sooner in life. ↗
▶ Ep 20 · 26:03
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: Thoracoscopic lobectomy risks include bleeding, prolonged post-op mechanical ventilation, infections, air leak, pneumothorax, nerve injury, and mortality. ↗
▶ Ep 20 · 27:47
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The particular malignancy associated with CPAM is pleuropulmonary blastoma (PPB), with risk that the lesion at birth already has malignancy and risk of malignant transformation over a person's life. ↗
▶ Ep 20 · 30:17
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: A recent study published in April 2021 found that no prenatally diagnosed lesions had malignancy, but 10% of patients diagnosed postnatally had malignancy in their resected mass. ↗
▶ Ep 20 · 52:39
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The incidence of CPAMs is estimated to be about 1 in every 8,000 to 35,000 births. ↗
▶ Ep 20 · 52:53
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: 60% of prenatally diagnosed lung lesions are CPAMs, making them the most common prenatal lung lesion. ↗
Summaries Rod gave as host · Congenital Pulmonary Airway Malformation 15 summaries

Open the Congenital Pulmonary Airway Malformation collection →

The Full Story on CPAMs

▶ Ep 20 · 5:12
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The Stocker classification for CPAMs ranges from type 0 to type 4, moving from proximal to distal in the bronchial tree, with type 1 (distal bronchi/proximal bronchioles) being most common at 60-70% of cases. ↗
▶ Ep 20 · 6:57
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs typically grow during the first 20-25 weeks of gestation and plateau around week 28. ↗
▶ Ep 20 · 8:02
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The presence of hydrops is the strongest prognostic indicator of mortality in these patients. ↗
▶ Ep 20 · 8:02
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The presence of hydrops is the strongest prognostic indicator of mortality in fetuses with CPAMs. ↗
▶ Ep 20 · 8:41
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The CPAM volume ratio (CVR) is calculated as the CPAM's length times width times height times 0.52 divided by the head circumference. ↗
▶ Ep 20 · 9:14
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: In patients with CVR over 1.6, it is estimated that 75% develop hydrops. ↗
▶ Ep 20 · 10:14
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs are differentiated as microcystic (less than 5 millimeters) or macrocystic (larger than 5 millimeters). ↗
▶ Ep 20 · 22:25
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs are not well-visualized on chest X-rays and can regress or get smaller over time. ↗
▶ Ep 20 · 24:40
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: In the United States, most surgeons resect CPAMs even if asymptomatic, while in Europe and Canada, surgeons sometimes choose to monitor asymptomatic lesions and avoid surgery. ↗
▶ Ep 20 · 25:29
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The main reasons for operating on asymptomatic CPAMs are: risk of malignancy both at resection and from malignant transformation later, risk of infection that will make surgery more difficult, and better compensatory lung growth if operating sooner in life. ↗
▶ Ep 20 · 26:03
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: Thoracoscopic lobectomy risks include bleeding, prolonged post-op mechanical ventilation, infections, air leak, pneumothorax, nerve injury, and mortality. ↗
▶ Ep 20 · 27:47
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The particular malignancy associated with CPAM is pleuropulmonary blastoma (PPB), with risk that the lesion at birth already has malignancy and risk of malignant transformation over a person's life. ↗
▶ Ep 20 · 30:17
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: A recent study published in April 2021 found that no prenatally diagnosed lesions had malignancy, but 10% of patients diagnosed postnatally had malignancy in their resected mass. ↗
▶ Ep 20 · 52:39
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The incidence of CPAMs is estimated to be about 1 in every 8,000 to 35,000 births. ↗
▶ Ep 20 · 52:53
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: 60% of prenatally diagnosed lung lesions are CPAMs, making them the most common prenatal lung lesion. ↗
Summaries Rod gave as host · CPAM (congenital Pulmonary Airway Malformation) 15 summaries

Open the CPAM (congenital Pulmonary Airway Malformation) collection →

The Full Story on CPAMs

▶ Ep 4 · 5:12
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The Stocker classification for CPAMs ranges from type 0 to type 4, moving from proximal to distal in the bronchial tree, with type 1 (distal bronchi/proximal bronchioles) being most common at 60-70% of cases. ↗
▶ Ep 4 · 6:57
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs typically grow during the first 20-25 weeks of gestation and plateau around week 28. ↗
▶ Ep 4 · 8:02
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The presence of hydrops is the strongest prognostic indicator of mortality in these patients. ↗
▶ Ep 4 · 8:02
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The presence of hydrops is the strongest prognostic indicator of mortality in fetuses with CPAMs. ↗
▶ Ep 4 · 8:41
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The CPAM volume ratio (CVR) is calculated as the CPAM's length times width times height times 0.52 divided by the head circumference. ↗
▶ Ep 4 · 9:14
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: In patients with CVR over 1.6, it is estimated that 75% develop hydrops. ↗
▶ Ep 4 · 10:14
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs are differentiated as microcystic (less than 5 millimeters) or macrocystic (larger than 5 millimeters). ↗
▶ Ep 4 · 22:25
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs are not well-visualized on chest X-rays and can regress or get smaller over time. ↗
▶ Ep 4 · 24:40
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: In the United States, most surgeons resect CPAMs even if asymptomatic, while in Europe and Canada, surgeons sometimes choose to monitor asymptomatic lesions and avoid surgery. ↗
▶ Ep 4 · 25:29
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The main reasons for operating on asymptomatic CPAMs are: risk of malignancy both at resection and from malignant transformation later, risk of infection that will make surgery more difficult, and better compensatory lung growth if operating sooner in life. ↗
▶ Ep 4 · 26:03
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: Thoracoscopic lobectomy risks include bleeding, prolonged post-op mechanical ventilation, infections, air leak, pneumothorax, nerve injury, and mortality. ↗
▶ Ep 4 · 27:47
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The particular malignancy associated with CPAM is pleuropulmonary blastoma (PPB), with risk that the lesion at birth already has malignancy and risk of malignant transformation over a person's life. ↗
▶ Ep 4 · 30:17
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: A recent study published in April 2021 found that no prenatally diagnosed lesions had malignancy, but 10% of patients diagnosed postnatally had malignancy in their resected mass. ↗
▶ Ep 4 · 52:39
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The incidence of CPAMs is estimated to be about 1 in every 8,000 to 35,000 births. ↗
▶ Ep 4 · 52:53
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: 60% of prenatally diagnosed lung lesions are CPAMs, making them the most common prenatal lung lesion. ↗
Summaries Rod gave as host · Fetal Surgery 15 summaries

Open the Fetal Surgery collection →

The Full Story on CPAMs

▶ Ep 17 · 5:12
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The Stocker classification for CPAMs ranges from type 0 to type 4, moving from proximal to distal in the bronchial tree, with type 1 (distal bronchi/proximal bronchioles) being most common at 60-70% of cases. ↗
▶ Ep 17 · 6:57
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs typically grow during the first 20-25 weeks of gestation and plateau around week 28. ↗
▶ Ep 17 · 8:02
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The presence of hydrops is the strongest prognostic indicator of mortality in these patients. ↗
▶ Ep 17 · 8:02
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The presence of hydrops is the strongest prognostic indicator of mortality in fetuses with CPAMs. ↗
▶ Ep 17 · 8:41
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The CPAM volume ratio (CVR) is calculated as the CPAM's length times width times height times 0.52 divided by the head circumference. ↗
▶ Ep 17 · 9:14
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: In patients with CVR over 1.6, it is estimated that 75% develop hydrops. ↗
▶ Ep 17 · 10:14
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs are differentiated as microcystic (less than 5 millimeters) or macrocystic (larger than 5 millimeters). ↗
▶ Ep 17 · 22:25
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: CPAMs are not well-visualized on chest X-rays and can regress or get smaller over time. ↗
▶ Ep 17 · 24:40
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: In the United States, most surgeons resect CPAMs even if asymptomatic, while in Europe and Canada, surgeons sometimes choose to monitor asymptomatic lesions and avoid surgery. ↗
▶ Ep 17 · 25:29
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The main reasons for operating on asymptomatic CPAMs are: risk of malignancy both at resection and from malignant transformation later, risk of infection that will make surgery more difficult, and better compensatory lung growth if operating sooner in life. ↗
▶ Ep 17 · 26:03
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: Thoracoscopic lobectomy risks include bleeding, prolonged post-op mechanical ventilation, infections, air leak, pneumothorax, nerve injury, and mortality. ↗
▶ Ep 17 · 27:47
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The particular malignancy associated with CPAM is pleuropulmonary blastoma (PPB), with risk that the lesion at birth already has malignancy and risk of malignant transformation over a person's life. ↗
▶ Ep 17 · 30:17
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: A recent study published in April 2021 found that no prenatally diagnosed lesions had malignancy, but 10% of patients diagnosed postnatally had malignancy in their resected mass. ↗
▶ Ep 17 · 52:39
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: The incidence of CPAMs is estimated to be about 1 in every 8,000 to 35,000 births. ↗
▶ Ep 17 · 52:53
host summary Rod Gerardo and Ellen Ancisco summarizing the discussion: 60% of prenatally diagnosed lung lesions are CPAMs, making them the most common prenatal lung lesion. ↗